Chemist + Druggist is part of Pharma Intelligence UK Limited

This is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
Tags:
Funding Products Clinical

2 strengths of meloxicam among final 8 price concessions for September

  • News

The Department of Health and Social Care and the National Assembly for Wales have agreed concessionary prices for the following eight items for September 2019 prescriptions.

An initial 18 prices for the month were announced on September 20, and a further 19 announced on September 24.

Drug
Strength
Form
Price
Celecoxib
200mg
capsules (30)
£8.29
Desmopressin
200 micrograms
tablets (30)
£17.39
Hydroxyzine
25mg
tablets (28)
£1.02
Hydroxyzine
10mg
tablets (84)
£2.85
Irbesartan
75mg
tablets (28)
£3.15
Meloxicam
7.5mg
tablets (30)
£1.75
Meloxicam
15mg
tablets (30)
£2.60
Topiramate
100mg
tablets (60)
£22.21
Table

View full table

Do these reflect the prices you have paid in September so far?

Related Content

Topics

         
Pharmacist Manager
Barnsley
£30 per hour

Apply Now
Tags:
Funding Products Clinical
Latest News & Analysis

Stop smoking: 10% rise in people seeking to quit in pharmacies

Community pharmacist named new Cegedim Rx UK managing director

Turning over a new leaf

Opinion: Even the cleverest analysis will only prolong the medicine shortage

See All
UsernamePublicRestriction

Register

CD006118

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Thank you for submitting your question. We will respond to you within 2 business days. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel


This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By